Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$1.69B |
| 2 |
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$1.32B |
| 3 |
Vanguard Total Bond Market
BND
|
+$1.21B |
| 4 |
SPDR Gold Trust
GLD
|
+$970M |
| 5 |
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
|
+$842M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$7.66B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$5.23B |
| 3 |
Accenture
ACN
|
+$1.14B |
| 4 |
Advanced Micro Devices
AMD
|
+$1.13B |
| 5 |
Vanguard Short-Term Bond ETF
BSV
|
+$635M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.44% |
| 2 | Financials | 11.14% |
| 3 | Consumer Discretionary | 8.06% |
| 4 | Healthcare | 8.02% |
| 5 | Communication Services | 7.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1976
Kulicke & Soffa
KLIC
$5.01B
| $56.1M | ﹤0.01% |
1,230,330
+77,527
| +7% | +$3.28M |
|
1977
Moelis & Co
MC
$4.9B
| $55.9M | ﹤0.01% |
813,212
-24,036
| -3% | -$1.6M |
|
1978
iShares 10+ Year Investment Grade Corporate Bond ETF
IGLB
$2.79B
| $55.9M | ﹤0.01% |
1,107,623
+492,472
| +80% | +$25.2M |
|
1979
Pearson
PSO
$9.66B
| $55.8M | ﹤0.01% |
3,971,424
+1,015,739
| +34% | +$14M |
|
1980
Nuveen ESG Mid-Cap Growth ETF
NUMG
$371M
| $55.6M | ﹤0.01% |
1,165,326
+42,864
| +4% | +$2.05M |
|
1981
Nuveen ESG Large-Cap Value ETF
NULV
$2.28B
| $55.5M | ﹤0.01% |
1,232,845
+31,083
| +3% | +$1.39M |
|
1982
US Global Jets ETF
JETS
$826M
| $55.5M | ﹤0.01% |
1,977,280
-3,521,937
| -64% | -$91.5M |
|
1983
Corcept Therapeutics
CORT
$12.2B
| $55.4M | ﹤0.01% |
1,592,059
+405,081
| +34% | +$31.8M |
|
1984
NewMarket
NEU
$8.51B
| $55.1M | ﹤0.01% |
80,182
-824
| -1% | -$629K |
|
1985
ACM Research
ACMR
$5.77B
| $54.9M | ﹤0.01% |
1,392,306
+515,340
| +59% | +$19.2M |
|
1986
Atlantic Union Bankshares
AUB
$6.07B
| $54.9M | ﹤0.01% |
1,555,413
+204,407
| +15% | +$7.02M |
|
1987
Upwork
UPWK
$1.03B
| $54.8M | ﹤0.01% |
2,765,286
-2,003,749
| -42% | -$36.7M |
|
1988
Vontier
VNT
$4.52B
| $54.7M | ﹤0.01% |
1,471,568
-59,341
| -4% | -$2.27M |
|
1989
Invesco S&P Ultra Dividend Revenue ETF
RDIV
$1.39B
| $54.7M | ﹤0.01% |
1,050,996
-2,798
| -0.3% | -$146K |
|
1990
Pacer US Large Cap Cash Cows Growth Leaders ETF
COWG
$2.31B
| $54.7M | ﹤0.01% |
1,553,074
-1,012,589
| -39% | -$36M |
|
1991
First Interstate BancSystem
FIBK
$3.66B
| $54.6M | ﹤0.01% |
1,578,719
+325,213
| +26% | +$10.6M |
|
1992
NorthWestern Energy
NWE
$4.36B
| $54.6M | ﹤0.01% |
846,080
+57,119
| +7% | +$3.62M |
|
1993
Krystal Biotech
KRYS
$9.87B
| $54.6M | ﹤0.01% |
221,481
-13,097
| -6% | -$2.76M |
|
1994
Cognex
CGNX
$10.4B
| $54.6M | ﹤0.01% |
1,517,130
+86,413
| +6% | +$3.5M |
|
1995
BlackRock Credit Allocation Income Trust
BTZ
$957M
| $54.6M | ﹤0.01% |
5,039,088
-222,730
| -4% | -$2.44M |
|
1996
ALPS International Sector Dividend Dogs ETF
IDOG
$563M
| $54.6M | ﹤0.01% |
1,415,057
+150,309
| +12% | +$5.6M |
|
1997
Wendy's
WEN
$1.63B
| $54.6M | ﹤0.01% |
6,549,066
+357,814
| +6% | +$3.09M |
|
1998
Schwab US Mid-Cap ETF
SCHM
$15.2B
| $54.5M | ﹤0.01% |
1,812,779
-788,284
| -30% | -$23.5M |
|
1999
Cohen & Steers Infrastructure Fund
UTF
$3.02B
| $54.5M | ﹤0.01% |
2,259,569
+171,998
| +8% | +$4.13M |
|
2000
State Street SPDR S&P 400 Mid Cap Value ETF
MDYV
$2.88B
| $54.5M | ﹤0.01% |
643,475
-22,752
| -3% | -$1.9M |
|
Similar funds
Morgan Stanley's Q4 2025 Portfolio in Review
As of Q4 2025, Morgan Stanley held 8,587 positions worth $1.67T, up 1.4% from $1.65T the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Morgan Stanley's Q4 2025 filing shows 427 new, 3,946 increased, 2,962 reduced and 384 closed positions. Its largest new stake was Medline Inc: 15,162,060 shares worth $637M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $7.66B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.
- Morgan Stanley's largest Q4 2025 buy was Medline Inc: 15,162,060 shares worth $637M.
- Morgan Stanley added most to Vanguard FTSE Developed Markets ETF in Q4 2025, an estimated $1.69B increase.
- Morgan Stanley's biggest Q4 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $7.66B.
- Morgan Stanley fully exited Mr. Cooper in Q4 2025, selling an estimated $312M.
- Morgan Stanley's ten largest holdings make up 22% of its $1.67T portfolio in Q4 2025.
- Morgan Stanley opened 427 new positions and closed 384 in Q4 2025.
- Morgan Stanley's portfolio value rose 1.4% quarter-over-quarter to $1.67T.
Based on Morgan Stanley's 13F filing for Q4 2025, filed 13 Feb 2026.